1.
Roche-Lestienne C, Darre S, Lai J, Facon T, Guilhot J, Preudhomme C. Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib. Haematologica 2005; 90(1):131-133.